1998
DOI: 10.1515/cclm.1998.131
|View full text |Cite
|
Sign up to set email alerts
|

Kinetic Study of Apo B100 Containing Lipoprotein Metabolism Using Amino Acids Labeled with Stable Isotopes: Methodological Aspects

Abstract: Kinetic disturbances of lipoprotein metabolism are important to know for a better understanding of lipid diseases or effects of drugs. These kinetic aspects were previously studied with radioactive tracers. The ethical concerns related to these tracers can be now overcome at a reasonable cost with the new development of small bench top mass spectrometers and the increased production of stable isotope tracers. In this review, we will discuss some methodological aspects related to stable isotope tracers and the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2002
2002
2017
2017

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 44 publications
0
7
0
Order By: Relevance
“…We used single-compartment models to describe the dynamic aspects of water metabolism both in mother and its litter related by milk flow which led to a bicompartmental model (Fig 1). The SAAM II program was used to fit the model to the observed tracer data by a weighed-least-squares approach to find the best fit as previously described [18] and to determine the parameters of the model. Implicit in the use of this model is the assumption that each animal remains in steady state with respect to its total body water turnover during the time course of the study.…”
Section: Methodsmentioning
confidence: 99%
“…We used single-compartment models to describe the dynamic aspects of water metabolism both in mother and its litter related by milk flow which led to a bicompartmental model (Fig 1). The SAAM II program was used to fit the model to the observed tracer data by a weighed-least-squares approach to find the best fit as previously described [18] and to determine the parameters of the model. Implicit in the use of this model is the assumption that each animal remains in steady state with respect to its total body water turnover during the time course of the study.…”
Section: Methodsmentioning
confidence: 99%
“…Each animal received intravenously a primed constant tracer infusion (10 µmol kg −1 h −1 for [5,5,5‐ 2 H 3 ]leucine and 2 µmol kg −1 min −1 for [1,2 13 C] acetate) for 8 h. Venous blood samples were withdrawn in tubes containing ethylene diamine tetraacetic acid (EDTA, final concentration of 0·2‐mmol L −1 tubes (Venoject, Paris, France) and dithiobisnitrobenzoic acid as an inhibitor of the LCAT reaction (final concentration 0·2 mmol L −1 ) at baseline, every 15 min during the first hour and then hourly until the end of the infusion. Then five blood samples were collected during the 18 h after the end of the infusion in order to cumulate specific advantages of both perfusion and bolus administration for adjustment procedures [9]. Plasma was immediately separated by centrifugation for 10 min at 4 °C; sodium azide, an inhibitor of bacterial growth, and Pefabloc SC (Interchim, Montluçon, France), a protease inhibitor, were added to the blood samples.…”
Section: Methodsmentioning
confidence: 99%
“…23 A forcing function determined with SAAMII program through interpolation between experimental data and corresponding to the time course of plasma leucine enrichment was used to drive the appearance of leucine tracer into apoB100 of the different lipoprotein fractions. 24 For comparison between the 3 groups (PCSK9-mutated patients, heterozygous FH, and controls) the VLDL1a, VLDL2, and VLDL1R data were presented as VLDL delipidation rate and VLDL fractional catabolic rate (FCR), which represents the sum of delipidation and direct removal rate. The VLDL conversion rate was calculated as VLDL2 delipidation flux divided by total VLDL mass.…”
Section: Modelingmentioning
confidence: 99%